The authoritative insight into companies at a strategic and local level.
Each individual profile analyzes the critical components that make up a pharmaceutical company, providing a clear assessment of the relative strengths and weaknesses of a company's business strategy.
-
100 full in-depth profiles published over 12 months, covering all major pharmaceutical companies worldwide
-
Generic, Biotechnology and Drug Delivery companies
-
Includes IMS Health sales data on products and therapies
-
In depth product and R&D reviews, including clinical trial, lifecycle management, competition and analysts forecasts
-
Mergers and acquisitions; licensing agreements
-
Forecasts and comments from leading financial analysts
Monthly Updates and 12-month Comprehensive Reviews
Profiles are published and updated on a monthly basis as follows:
-
Up to 10 profiles are fully reviewed each month and will feature brand new information covering all aspects of the company’s performance.
-
Any major news released on a company will be included each month if particularly relevant, often covering one particular aspect such as a new product launch or an acquisition.
